Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,179.75
(
0.61%
)
US TECH 100
26,578.00
(
0.44%
)
Dow Jones
49,542.42
(
1.39%
)
Brent Oil
108.90
(
-3.10%
)
Bitcoin
76,116.95
(
0.45%
)
News Focus
News Focus
Post# of 257471
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122912
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 247123

Tuesday, 05/30/2023 1:14:33 PM

Tuesday, May 30, 2023 1:14:33 PM

Post# of 257471
RAIN shelves Milademetan program—reduces workforce 65%:

https://www.globenewswire.com/news-release/2023/05/30/2678353/0/en/Rain-Oncology-Provides-Company-Update-and-Outlines-Strategic-Priorities-of-Milademetan-Clinical-Programs.html

RAIN is now a shell company with a decent amount of cash and a deeply negative enterprise value, which makes it an attractive candidate for a reverse-merger.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today